Type 2 & other diabetes

Economic Costs of Diabetes in the U.S. in 2022

Diabetes CarePublished Cost-of-illness study

Authors' conclusion

The inflation-adjusted direct medical costs of diabetes are estimated to rise 7% from 2017 and 35% from 2012 calculations (stated in 2022 dollars). Following decades of steadily increasing prevalence of diabetes, the overall estimated prevalence in 2022 remains relatively stable in comparison to 2017. However, the absolute number of people with diabetes has grown and contributes to increased health care expenditures, particularly per capita spending on inpatient hospital stays and prescription medications. The enormous economic toll of diabetes continues to burden society through direct medical and indirect costs.

Study context

Population
U.S. population in 2022 with diagnosed diabetes; data from national surveys (2015–2020), Medicare standard analytic files (2020) and commercial claims (2018 to 2021)
Outcome
Economic burden (health resource use, direct medical and indirect costs) attributable to diagnosed diabetes
Follow-up
2022
Methodological detailsCost of Diabetes Economic Model, population-based
  • Cost of Diabetes Economic Model
  • Population-based

Main finding

As reported in the abstract

Economic burden of diagnosed diabetes
Total estimated cost of diagnosed diabetes
$412.9 billion
Direct medical costs
$306.6 billion
Indirect costs attributable to diabetes
$106.3 billion
Share of U.S. health care dollars for care of people with diagnosed diabetes
1 in 4
Share of those dollars attributable to diabetes
61%
Mean annual medical expenditures per person with diabetes
$19,736
Of which attributable to diabetes (approximately)
$12,022
Medical expenditures vs expected without diabetes
2.6 times higher
Glucose-lowering medications and diabetes supplies, share of direct medical costs attributable to diabetes
∼17%
Indirect cost: reduced employment due to disability
$28.3 billion
Indirect cost: presenteeism
$35.8 billion
Indirect cost: lost productivity due to 338,526 premature deaths
$32.4 billion

Observational data: associations, not effects.

Original publication

Economic Costs of Diabetes in the U.S. in 2022. Diabetes Care. Published 1 November 2023. doi:10.2337/dci23-0085

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.